Exeevo Inc.

Based in New York, US, and founded in 2017, Exeevo Inc. operates as a provider of AI-powered customer engagement platforms to pharmaceutical companies and healthcare organizations globally. In December 2024, Valsoft Corporation Inc. , a portfolio company of Coatue Management and Viking Global Investors, acquired Exeevo Inc.

As of 2024, the company is led by its CEO, Derek J. Evans. Exeevo offers a comprehensive suite of customer relationship management (CRM) solutions intended for the life sciences sector. Its core product is an AI-powered platform that integrates sales, marketing, medical, and service teams into a unified customer engagement ecosystem.

The platform facilitates efficient navigation throughout the customer journey by providing a 360-degree view of healthcare professionals (HCPs) and organizations, thereby improving engagement and decision-making capabilities. Exeevo's offerings include specialized tools for medical teams, marketing automation for orchestrating omnichannel campaigns, event management for lifecycle oversight, and robust content management systems. These products are tailored for clients in the life sciences industry, including pharmaceutical companies and healthcare organizations, with a customer base spanning North America, Europe, and Asia. Exeevo generates revenue primarily through subscription-based models, allowing clients to access its suite of CRM solutions, including its flagship AI-enabled platform, for a licensing fee.

Clients benefit from the ability to use various applications within the platform either individually or collectively. The company structures its transactions as B2B engagements, partnering with life sciences firms to enhance their customer engagement strategies. The company also aims to expand into additional markets in Europe and Asia by mid-2026, leveraging funding from the acquisition to support these initiatives.